BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36281060)

  • 1. Juglone promotes antitumor activity against prostate cancer via suppressing glycolysis and oxidative phosphorylation.
    Hu C; Xu H; Li Z; Liu D; Zhang S; Fang F; Wang L
    Phytother Res; 2023 Feb; 37(2):515-526. PubMed ID: 36281060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells.
    Fukushi A; Kim HD; Chang YC; Kim CH
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL; Qin L; Liu HC; Candas D; Fan M; Li JJ
    PLoS One; 2015; 10(3):e0121046. PubMed ID: 25807077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
    Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
    Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
    Lu J; Tan M; Cai Q
    Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Mitochondrial Metabolism in Prostate Cancer with Triterpenoids.
    Mamouni K; Kallifatidis G; Lokeshwar BL
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells.
    Ippolito L; Marini A; Cavallini L; Morandi A; Pietrovito L; Pintus G; Giannoni E; Schrader T; Puhr M; Chiarugi P; Taddei ML
    Oncotarget; 2016 Sep; 7(38):61890-61904. PubMed ID: 27542265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells.
    Liu Z; Sun Y; Tan S; Liu L; Hu S; Huo H; Li M; Cui Q; Yu M
    Tumour Biol; 2016 May; 37(5):6661-71. PubMed ID: 26646563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.
    Mathupala SP; Ko YH; Pedersen PL
    Semin Cancer Biol; 2009 Feb; 19(1):17-24. PubMed ID: 19101634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
    Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCA-phospholipid-glycolysis targeted triple therapy effectively suppresses ATP production and tumor growth in glioblastoma.
    Yang S; Zhao J; Cui X; Zhan Q; Yi K; Wang Q; Xiao M; Tan Y; Hong B; Fang C; Kang C
    Theranostics; 2022; 12(16):7032-7050. PubMed ID: 36276638
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitro.
    Lai HW; Kasai M; Yamamoto S; Fukuhara H; Karashima T; Kurabayashi A; Furihata M; Hanazaki K; Inoue K; Ogura SI
    Biol Open; 2023 Apr; 12(4):. PubMed ID: 36919762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium.
    Mitaishvili E; Feinsod H; David Z; Shpigel J; Fernandez C; Sauane M; de la Parra C
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):99. PubMed ID: 38538285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2.
    Xu D; Jin J; Yu H; Zhao Z; Ma D; Zhang C; Jiang H
    J Exp Clin Cancer Res; 2017 Mar; 36(1):44. PubMed ID: 28320429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers.
    Chen CL; Lin CY; Kung HJ
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease.
    Green HJ; Bombardier E; Burnett M; Iqbal S; D'Arsigny CL; O'Donnell DE; Ouyang J; Webb KA
    Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R935-41. PubMed ID: 18635455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation.
    Niture S; Lin M; Odera JO; Moore J; Zhe H; Chen X; Suy S; Collins SP; Kumar D
    Int J Biochem Cell Biol; 2021 Jan; 130():105885. PubMed ID: 33227392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen.
    Pedersen PL
    J Bioenerg Biomembr; 2007 Jun; 39(3):211-22. PubMed ID: 17879147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the low inhibitory specificity of oxamate, aminooxyacetate and dichloroacetate on cancer energy metabolism.
    Moreno-Sánchez R; Marín-Hernández Á; Del Mazo-Monsalvo I; Saavedra E; Rodríguez-Enríquez S
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3221-3236. PubMed ID: 27538376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cells.
    Li X; Han G; Li X; Kan Q; Fan Z; Li Y; Ji Y; Zhao J; Zhang M; Grigalavicius M; Berge V; Goscinski MA; Nesland JM; Suo Z
    Oncotarget; 2017 Jul; 8(28):46363-46380. PubMed ID: 28624784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.